comparemela.com

Latest Breaking News On - பாஸ்கல் நீகெண் - Page 1 : comparemela.com

Helix BioPharma Corp Announces Changes to the Company s Board of Directors and Management

Helix BioPharma Corp Announces Changes to the Company s Board of Directors and Management
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Helix BioPharma Corp Announces Fiscal Third Quarter 2021 Results

Helix BioPharma Corp. Announces Fiscal Third Quarter 2021 Results OVERVIEW The Company reported a net loss and total comprehensive loss of $2,554,000 and $5,268,000 for the three and nine-month periods ended April 30, 2021. For the three and nine-month periods ended April 30, 2020, net loss and total comprehensive loss totalled $2,489,000 and $6,896,000, respectively. The net loss and total comprehensive loss for the three-month period ending April 30, 2021, includes a net loss of $nil (2020 - $198,000) and for the nine-month period ending April 30, 2021 a gain of $1,536,000 (2020 - loss of $465,000) from discontinued operations. The Company lost control of its subsidiary in Poland during the three-month period ending October 31, 2020 though continued to exert significant influence until December 22, 2020 when the Company disposed of its remaining interest for gross proceeds of $2,308,000.

Helix BioPharma Corp Announces Institutional Investment for Gross Proceeds of up to CAD$10 million

Helix BioPharma Corp. Announces Institutional Investment for Gross Proceeds of up to CAD$10 million RICHMOND HILL, ON / ACCESSWIRE / May 11, 2021 / Helix BioPharma Corp.(TSX:HBP)( Helix or the Company ), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has entered into a definitive convertible security funding agreement (the Agreement ) with Lind Global Macro Fund, LP, a New York based institutional investment fund managed by The Lind Partners, LLC (together, Lind ). Under the terms of the Agreement, an initial CAD$3.5 million will be funded pursuant to the issuance of a convertible security (a Convertible Security ) which is expected to occur on or around May 12, 2021 ( First Tranche ). The Agreement also contemplates the issuance of a second Convertible Security upon the mutual agreement of the Company and Lind for gross proceeds to the Company of up to CAD$6.5 million (the Second Tranche ).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.